Skip to main content

Pharma news oct 2019

Major points in pharma times Oct 19

1.Stephan and James Huang to develop vaccines for cancer. It works by mRNA encoding for protein that neutralize cancer cells.
2. Lonsurf(triflurodine) to treat gastric cancer. ROCHE's Tensertiq(atezolizumab) to treat metastatic lung cancer.
3.Novartis's Ofatumumam more effective than Sanofi's Aufagio to treat multiple sclerosis.
4UK uses biosimilar medicines , saves £200
5.Statins to be prescribed by pharmacist .

Main points in pharmacy times: Oct19

Drug therapy of choice to treat inflammation
-biological DMARDS (tissue necrotic factor blocker)::subcutaneous olimumab
-convention DMARDS :methotrexate
-Tcell costimulation modulator
-Non biological DMARDs 

*Disease-modifying antirheumatic drugs (DMARDs) are a group of medications commonly used in people with rheumatoid arthritis. Some of these drugs are also used in treating other conditions such as ankylosing spondylitis, psoriatic arthritis, and systemic lupus erythematosus.




Comments

Post a Comment

Popular posts from this blog

Brain connectivity improves human aesthetic responses to music

Brain connectivity improves human aesthetic responses to music Abstract: 1. white matter connectivity between sensory processing areas in the superior temporal gyrus and emotional and social processing areas in the insula and medial prefrontal cortex explains individual differences in reward sensitivity to music. 2.  findings provide the first evidence for a neural basis of individual differences in sensory access to the reward system, and suggest that social–emotional communication through the auditory channel may offer an evolutionary basis for music making as an aesthetically rewarding function in humans. 3.carried out by -- Using a combination of survey data, behavioral and psychophysiological measures and diffusion tensor imaging, Conclusion: Results from diffusion tensor imaging show that white matter connectivity between auditory perceptual regions (pSTG) and regions of the brain important for emo- tional and social processing (aIns, mPFC) reflect individual diffe...
Post a Comment
Read more

pharmacogenomics

Pharmacogenomics 1.Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.  2.pros Improve drug safety, and reduce ADRs; Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing; Improve drug discovery targeted to human disease; and Improve proof of principle for efficacy trials 3.genome-wide technology on pharmacogenomics of mental illnesses including schizophrenia (SCZ), autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD), and obsessive compulsive disorder (OCD). 4.The effectiveness and toxicities of medications used in secondary stroke prophylaxis, dementia, seizure disorders, multiple sclerosis (MS), and Parkinson disease (PD) are all influenced by genetic polymorphisms. 5.pharmacogenomic  used to study neurodegene...
Post a Comment
Read more